| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Products | ||||||
- | - | 535 | - | - | - | - |
Services | ||||||
- | - | 3,400 | - | - | - | - |
Products | ||||||
- | - | - | 37,510 | 51,381 | 50,044 | - |
Services | ||||||
- | - | - | 15,657 | 15,576 | 12,905 | - |
Revenues | ||||||
6,301 | 3,756 | 3,935 | 53,167 | 66,957 | 62,949 | 50,572 |
Products | ||||||
- | - | 494 | - | - | - | - |
Services | ||||||
- | - | 738 | - | - | - | - |
Products | ||||||
- | - | - | 29,025 | 40,763 | 38,906 | - |
Services | ||||||
- | - | - | 9,215 | 6,865 | 5,303 | - |
Cost of Revenues | ||||||
1,609 | 1,076 | 1,232 | 38,240 | 47,628 | 44,209 | 38,317 |
Gross Profit | ||||||
4,692 | 2,680 | 2,703 | 14,927 | 19,329 | 18,740 | 12,255 |
Operating Expenses | ||||||
Research and development | ||||||
3,893 | 1,231 | 964 | 2,277 | 635 | 616 | - |
Sales and marketing | ||||||
3,043 | 1,726 | 2,367 | 8,500 | 11,531 | 9,966 | - |
General and administrative | ||||||
13,660 | 14,149 | 10,874 | 15,269 | 14,226 | 11,935 | - |
Compensation and related benefits | ||||||
- | - | - | - | - | - | 8,859 |
Professional fees and consulting expenses | ||||||
- | - | - | - | - | - | 1,700 |
Occupancy | ||||||
- | - | - | - | - | - | 417 |
Acquisition related costs | ||||||
1,277 | 108 | 5 | 876 | 355 | 1,016 | 1,813 |
Impairment of goodwill | ||||||
- | 636 | 587 | 7,400 | 0 | - | - |
Costs associated with public offering | ||||||
- | - | - | - | - | - | 543 |
Amortization of intangibles | ||||||
3,629 | 3,232 | 2,936 | 4,328 | 3,994 | 2,913 | 822 |
Other administrative | ||||||
- | - | - | - | - | - | 2,017 |
Total Operating Expenses | ||||||
25,502 | 21,082 | 17,733 | 38,650 | 30,741 | 26,446 | 16,171 |
Loss from Operations | ||||||
-20,810 | -18,402 | -15,030 | -23,723 | -11,412 | -7,706 | -3,916 |
Other Income (Expense) | ||||||
Interest expense, net | ||||||
-2,277 | -1,241 | -1,884 | -1,743 | -448 | -387 | -315 |
Loss on exchange of debt for equity | ||||||
-294 | - | - | - | - | - | - |
Loss on the settlement of obligation | ||||||
- | - | - | - | -85 | - | - |
Reserve for the recoverability of note receivable | ||||||
- | - | - | 1,077 | 0 | - | - |
Gain (Loss) on the settlement of obligation | ||||||
- | - | - | - | - | 394 | 155 |
Change in fair value of shares to be issued | ||||||
- | - | - | 13 | - | 0 | -489 |
Change in fair value of derivative liability | ||||||
- | 48 | 555 | 51 | 0 | - | - |
Gain on the sale of Sysorex Arabia | ||||||
- | 23 | - | - | - | - | - |
Provision for valuation allowance on related party loan - held for sale | ||||||
-10,627 | - | - | - | - | - | - |
Extinguishment loss for debt modification | ||||||
- | - | -653 | - | - | - | - |
Reserve for the recoverability of note receivable | ||||||
- | - | - | 1,077 | 0 | - | - |
Extinguishment loss for debt modification | ||||||
- | - | - | 0 | - | - | - |
Other expense | ||||||
- | - | - | 266 | - | - | - |
Other income | ||||||
- | - | - | - | - | 47 | 30 |
Other income/(expense) | ||||||
-558 | -211 | -1,069 | -3,022 | 25 | 54 | -619 |
Change in fair value of shares to be issued | ||||||
- | - | - | - | 211 | - | - |
Total Other Income (Expense) | ||||||
-13,756 | -1,381 | -3,051 | - | -297 | - | - |
Net Loss from Operations, before tax | ||||||
-34,566 | -19,783 | - | - | - | -7,652 | -4,535 |
Income tax benefit | ||||||
-584 | - | - | - | - | 0 | 0 |
Net Loss from Continuing Operations | ||||||
-33,982 | -19,783 | -18,081 | -26,745 | -11,709 | - | - |
Loss from Discontinued Operations, Net of Tax | ||||||
- | -4,778 | -16,949 | -758 | -20 | - | - |
Net Loss | ||||||
-33,982 | -24,561 | -35,030 | -27,503 | -11,729 | -7,652 | -4,535 |
Net Loss Attributable to Non-controlling Interest | ||||||
9 | 11 | -17 | -389 | -10 | -116 | -272 |
Net Loss Attributable to Stockholders of Inpixon | ||||||
-33,991 | -24,572 | -35,013 | -27,114 | -11,719 | -7,536 | -4,263 |
Deemed dividend to preferred stockholders | ||||||
- | -6,407 | -756 | 0 | - | - | - |
Deemed dividend for triggering of warrant down round feature | ||||||
-1,250 | -13,645 | - | - | - | - | - |
Net Loss Attributable to Common Stockholders | ||||||
-35,241 | -44,624 | -35,769 | -27,114 | - | - | - |
Net Loss Per Basic and Diluted Common Share | ||||||
Loss from continuing operations | ||||||
-47.52 | -2,322.30 | -2,902.47 | -461.89 | -248.76 | - | - |
Loss from discontinued operations | ||||||
- | -278.47 | -2,611.56 | -13.09 | -0.21 | - | - |
Net Loss Per Share - Basic and Diluted | ||||||
-47.52 | -2,600.77 | -5,511.40 | -468.26 | -248.97 | -0.42 | -0.35 |
Weighted Average Shares Outstanding | ||||||
Basic and Diluted | ||||||
741 | 17 | 6 | 57,904 | 47 | 18,111 | 12,287 |
Net Loss | ||||||
-33,982 | -24,561 | -35,030 | -27,503 | -11,729 | - | -4,535 |
Unrealized foreign exchange gain/(loss) from cumulative translation adjustments | ||||||
- | - | - | - | - | - | 0 |
Unrealized holding gains in marketable securities including reclassification adjustment of realized gains included in net income | ||||||
- | - | - | - | - | - | 3 |
Comprehensive Loss | ||||||
- | - | - | - | - | - | -4,532 |